{"component": "definition", "props": {"groups": [{"samples": [{"hash": "5ATWKk3APn8", "uri": "http://www.rld.state.nm.us/uploads/FileLinks/30148500fc59448da00d2ed9b2659868/April_2014_Approved_Meeting_Minutes.pdf", "label": "www.rld.state.nm.us", "score": 7.2409308693, "published": false}, {"hash": "3RM7GwFQ4yK", "uri": "https://www.rld.state.nm.us/uploads/FileLinks/30148500fc59448da00d2ed9b2659868/April_2014_Draft_Minutes_2.pdf", "label": "www.rld.state.nm.us", "score": 7.2217659138, "published": false}, {"hash": "aFeF799ezsE", "uri": "https://www.rld.state.nm.us/uploads/FileLinks/30148500fc59448da00d2ed9b2659868/April_2014_Draft_Minutes___Copy_1.pdf", "label": "www.rld.state.nm.us", "score": 7.219028063, "published": false}], "size": 16, "snippet": "means documented evidence providing a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes.", "snippet_links": [{"key": "specifications-and-quality", "type": "clause", "offset": [149, 175]}], "hash": "b6ce96eccb4b8cd0d8d0178ab316592c", "id": 1}, {"samples": [{"hash": "8EWqIbzafTs", "uri": "https://pharmacy.ca.gov/meetings/agendas/2024/24_apr_bd_mat_xiv.pdf", "label": "pharmacy.ca.gov", "score": 16.8677531077, "published": false}, {"hash": "eRJAQZQlgi3", "uri": "https://pharmacy.ca.gov/meetings/agendas/2024/24_apr_leg_mat.pdf", "label": "pharmacy.ca.gov", "score": 12.1293634497, "published": false}, {"hash": "6oQEsewFDoJ", "uri": "https://www.pharmacy.ca.gov/meetings/minutes/2023/23_apr_bd_min.pdf", "label": "www.pharmacy.ca.gov", "score": 9.7255304586, "published": false}], "size": 7, "snippet": "means demonstrating that when a process is repeated within specified limits, the process will consistently produce preparations complying with predetermined requirements. If any aspect of the process is changed, the process would need to be revalidated.", "snippet_links": [{"key": "the-process", "type": "clause", "offset": [77, 88]}, {"key": "complying-with", "type": "clause", "offset": [128, 142]}], "hash": "af0aa4efa7b161d5e30a214f518dc2fa", "id": 2}, {"samples": [{"hash": "lk5I5IYLbuv", "uri": "/contracts/lk5I5IYLbuv#process-validation", "label": "Asset Purchase Agreement (Medgenesis Inc)", "score": 18.0, "published": true}, {"hash": "hdrBj0Mu6GH", "uri": "/contracts/hdrBj0Mu6GH#process-validation", "label": "Asset Purchase Agreement (Medgenesis Inc)", "score": 18.0, "published": true}, {"hash": "ggk2Zv56xsZ", "uri": "/contracts/ggk2Zv56xsZ#process-validation", "label": "Asset Purchase Agreement (Medgenesis Inc)", "score": 18.0, "published": true}], "size": 4, "snippet": "means the successful completion of the testing and development process related to the leukocyte reagent component of Seller's Urine Chemistry Products, as identified in Exhibit H hereto.", "snippet_links": [{"key": "the-testing", "type": "definition", "offset": [35, 46]}, {"key": "development-process", "type": "clause", "offset": [51, 70]}, {"key": "related-to", "type": "clause", "offset": [71, 81]}, {"key": "of-seller", "type": "clause", "offset": [114, 123]}, {"key": "exhibit-h", "type": "definition", "offset": [169, 178]}], "hash": "17ec1dd9feab3b8e6b193ea319693a82", "id": 3}, {"samples": [{"hash": "exGuyCIDUCY", "uri": "https://risos-apa-production-public.s3.amazonaws.com/RICCC/REG_13245_20250108114048048.pdf", "label": "risos-apa-production-public.s3.amazonaws.com", "score": 17.7905083812, "published": false}, {"hash": "2C1I04PKXuC", "uri": "https://risos-apa-production-public.s3.amazonaws.com/DBR/10920/CON_10920_20200305095516.pdf", "label": "risos-apa-production-public.s3.amazonaws.com", "score": 10.0869267625, "published": false}, {"hash": "x5H13EXGTI", "uri": "https://risos-apa-production-public.s3.amazonaws.com/DBR/REG_12208_20211221145123.pdf", "label": "risos-apa-production-public.s3.amazonaws.com", "score": 9.1834360027, "published": false}], "size": 4, "snippet": "means the collection and evaluation of data from the process design stage throughout production, which establishes scientific evidence that a process is capable of consistently delivering quality products.", "snippet_links": [{"key": "evaluation-of-data", "type": "clause", "offset": [25, 43]}, {"key": "the-process", "type": "clause", "offset": [49, 60]}, {"key": "design-stage", "type": "definition", "offset": [61, 73]}, {"key": "scientific-evidence", "type": "definition", "offset": [115, 134]}, {"key": "capable-of", "type": "definition", "offset": [153, 163]}], "hash": "56f8906f815864c7d2bb14fa293aa48b", "id": 4}, {"samples": [{"hash": "266bZjYyDV1", "uri": "https://www.parlament.gv.at/PAKT/EU/XXVII/EU/10/86/EU_108698/imfname_11168203.pdf", "label": "www.parlament.gv.at", "score": 11.2669404517, "published": false}, {"hash": "4EcN9BZ9Rop", "uri": "https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52022PC0338", "label": "eur-lex.europa.eu", "score": 11.2655715264, "published": false}, {"hash": "aa2gTeE9aGD", "uri": "https://data.consilium.europa.eu/doc/document/ST-13802-2023-INIT/en/pdf", "label": "data.consilium.europa.eu", "score": 10.9075975359, "published": false}], "size": 4, "snippet": "means establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce results meeting predetermined specifications and quality attributes;", "snippet_links": [{"key": "specifications-and-quality", "type": "clause", "offset": [160, 186]}], "hash": "39c8695548c7e91b26349aeecab1a6f2", "id": 5}, {"samples": [{"hash": "f76BhNydBVB", "uri": "/contracts/f76BhNydBVB#process-validation", "label": "Development, License and Supply Agreement (Jazz Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "kk4ZcIkT4ye", "uri": "/contracts/kk4ZcIkT4ye#process-validation", "label": "Quality Agreement (Jazz Pharmaceuticals Inc)", "score": 18.0, "published": true}], "size": 2, "snippet": "All processes used in the manufacture and packaging of the Product", "snippet_links": [{"key": "the-product", "type": "clause", "offset": [55, 66]}], "hash": "6463e98e8e4159c8261f34aeb6909f9c", "id": 6}, {"samples": [{"hash": "iV62Ea0ik5y", "uri": "https://www.sec.gov/Archives/edgar/data/1561743/000156174317000053/exhibit101manufactureandsu.htm", "label": "Kindred Biosciences, Inc.", "score": 12.8494182067, "published": false}, {"hash": "gUkGWbaWFEQ", "uri": "https://ir.kindredbio.com/static-files/06cbe4fc-9ced-4885-b4db-009ecec7fc21", "label": "ir.kindredbio.com", "score": 9.9952087611, "published": false}], "size": 2, "snippet": "means the fully documented and agreed to activities to be undertaken to ensure that a manufacturing process, packaging process, testing methods or", "snippet_links": [{"key": "fully-documented", "type": "definition", "offset": [10, 26]}, {"key": "agreed-to", "type": "definition", "offset": [31, 40]}, {"key": "to-ensure", "type": "clause", "offset": [69, 78]}, {"key": "manufacturing-process", "type": "definition", "offset": [86, 107]}, {"key": "testing-methods", "type": "clause", "offset": [128, 143]}], "hash": "dd25e9e2612e839795c8e1ae3fc27a11", "id": 7}, {"samples": [{"hash": "3Fph9IeLM3v", "uri": "/contracts/3Fph9IeLM3v#process-validation", "label": "Supply Agreement (Universal Biosensors Inc)", "score": 24.0937713895, "published": true}, {"hash": "agcu29IVurq", "uri": "/contracts/agcu29IVurq#process-validation", "label": "Supply Agreement (Universal Biosensors Inc)", "score": 23.8254620123, "published": true}], "size": 2, "snippet": "means validation of the final manufacturing processes to be used for the initial shipment of each Product hereunder in accordance with the terms of the Collaboration Agreement.", "snippet_links": [{"key": "manufacturing-processes", "type": "clause", "offset": [30, 53]}, {"key": "initial-shipment", "type": "clause", "offset": [73, 89]}, {"key": "in-accordance-with", "type": "definition", "offset": [116, 134]}, {"key": "collaboration-agreement", "type": "definition", "offset": [152, 175]}], "hash": "2bdd54ce91a511c4faa5da2967933534", "id": 8}, {"samples": [{"hash": "2cQCOogMow8", "uri": "/contracts/2cQCOogMow8#process-validation", "label": "Distribution, Supply and License Agreement (Oculex Pharmaceuticals Inc /)", "score": 18.0, "published": true}], "size": 2, "snippet": "means establishment of documented evidence which provides a high degree of assurance that a specific process conducted by Oculex and/or any Third-Party Supplier, will consistently produce a particular Oculex Product meeting the Specification for such Oculex Product and quality [*] Confidential treatment requested with respect to certain portions of this exhibit attributes for that Oculex Product, in accordance with the FDA document entitled \"General Principles of Process Validation\", and other FDA documents and regulations, and any applicable similar regulations of any relevant foreign governments.", "snippet_links": [{"key": "establishment-of", "type": "clause", "offset": [6, 22]}, {"key": "party-supplier", "type": "definition", "offset": [146, 160]}, {"key": "the-specification", "type": "clause", "offset": [224, 241]}, {"key": "confidential-treatment-requested", "type": "definition", "offset": [282, 314]}, {"key": "with-respect-to", "type": "clause", "offset": [315, 330]}, {"key": "this-exhibit", "type": "definition", "offset": [351, 363]}, {"key": "in-accordance-with", "type": "definition", "offset": [400, 418]}, {"key": "the-fda", "type": "clause", "offset": [419, 426]}, {"key": "general-principles", "type": "definition", "offset": [446, 464]}, {"key": "fda-documents", "type": "clause", "offset": [499, 512]}, {"key": "and-regulations", "type": "clause", "offset": [513, 528]}], "hash": "f8f52be9b02dc0071196b0a0d0d5ac31", "id": 9}, {"samples": [{"hash": "ck3wUI2Y3md", "uri": "https://www.njcourts.gov/sites/default/files/mcl/allergan-biocell-textured-breast-implants/mastercomplaint.pdf", "label": "www.njcourts.gov", "score": 6.3333333333, "published": false}], "size": 2, "snippet": "means establishing by objective evidence that a process consistently produces a result or product meeting its predetermined specifications. See 21 C.F.R.", "snippet_links": [{"key": "objective-evidence", "type": "definition", "offset": [22, 40]}], "hash": "a6d3ca096f6bf079afcbd96a2bd94371", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIbcHJvY2Vzcy12YWxpZGF0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 59, "snippet": "means documented evidence providing a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes.", "title": "Process validation", "id": "process-validation", "examples": ["<strong>Process validation</strong> batches will not be included in determining the Yield Rate.", "As used herein, \u201cSubpar Yield\u201d means a yield in comparability runs in the Singapore Facility that is more than [***] lower than the average yield obtained in new <strong>Process validation</strong> runs conducted in the Walkersville Facility.", "Catalent shall <strong>Process validation</strong> Batches and perform validation services at prices to be agreed in writing between the parties.", "<strong>Process validation</strong> and transfer of the COLLABORATOR Process into Module is entirely the responsibility of COLLABORATOR.", "<strong>Process validation</strong> results are required to substantiate that manufacturing procedures are in place to minimize biological risks.", "Prior to the execution of this Agreement by the parties, the parties entered into that certain Quotation entitled \u201c<strong>Process Validation</strong> of Pirfenidone Manufacture Capsulation ([ * ]) dated July 28, 2009, a copy of which is attached hereto as Attachment A (the \u201cValidation Services Quotation\u201d), whereby Catalent shall perform for Client the qualification and <strong>Process validation</strong> services set forth therein (the \u201cValidation Services\u201d).", "Pursuant to the terms of a purchase order, sale agreement or other document to be separately agreed by the Parties or Licensee and Delphi, Licensor will support the necessary manufacturing Part Production Approval <strong>Process validation</strong> tests for the Licensed Products.", "<strong>Process validation</strong> assignments will first be offered by seniority to employees on the required shift, within the department, assigned within the applicable work area, and qualified to the applicable stations where the <strong>process validation</strong>(s) will take place.", "<strong>Process validation</strong> batches may be shipped prior to completion of the validation reports, if a letter of authorization is provided by Xanodyne Corporate Quality Assurance.", "Each Batch produced under this Agreement including those necessary to support the validation portion of Client\u2019s submissions for Regulatory Approvals, will be considered to be a \u201cDevelopment Batch\u201d until manufacturing, testing, storage methods and processes have been validated in accordance with industry standards (including, with respect to initial <strong>Process validation</strong> at the Facility, production of at least 3 consecutive Batches of Product that meet the applicable Specifications)."], "related": [["validation", "Validation", "Validation"], ["procurement-process", "Procurement Process", "Procurement Process"], ["manufacturing-process", "Manufacturing Process", "Manufacturing Process"], ["acceptance-testing", "Acceptance Testing", "Acceptance Testing"], ["bulk-drug-substance", "Bulk drug substance", "Bulk drug substance"]], "related_snippets": [], "updated": "2025-07-06T21:56:50+00:00"}, "json": true, "cursor": ""}}